sharon sanders
Editor-in-Chief & President
Autopsy of COVID-19 victims in China
Xiu-Wu Bian, the COVID-19 Pathology Team
Author Notes
National Science Review, nwaa123, https://doi.org/10.1093/nsr/nwaa123
Published:
06 June 2020
PDF
Abstract
Distribution of SARS-CoV-2 virus and pathological features of multiple organs in COVID-19 patients remains unclear, which interferes with the improvement of COVID-19 diagnosis and treatment. In this article, we summarize the pathological findings obtained from systematic autopsy (37 cases) and percutaneous multiple organ biopsy (“minimally invasive autopsy”, 54 cases). These findings should shed light on better understanding of the progression of COVID-19 infection and the means of more effective intervention.
----------------------
The postmortem discloses visible damages in the lung and immune organs in patients with COVID-19. Since some immune organs are SARS-CoV-2 positive with spleen atrophy, the immune organs may be another target organ by virus infection in addition to the lung, which emphasizes that clinical
diagnosis and treatment should consider the damages to immune system. We found that most of the deceased COVID-19 cases had mucous plug in
the alveoli and deep small airways, which might severely affect ventilation. The mechanisms of infection course and prevention measures were subject
of further investigation. In COVID-19 patients, pulmonary fibrosis occurred early and widely, suggesting that the requirement of early measures on
pulmonary fibrosis. In addition, the hyperplasia of pulmonary epithelial cells and the elevation of plasma carcinoembryonic antigen (CEA) in some patients
also require studies of the cause and follow-up.
In some deceased cases, nasopharyngeal swab test showed negative viral nucleic acid, but the acid could be detected in organs, suggesting that
current standard swab test for SARS-CoV-2 as an indicator for clinical cure and hospital discharge may not be adequate.
Detection of nuclear acids of SARS-CoV-2 in multiple organs of COVID-19 patients with severe conditions implies that the existence of SARS-
CoV-2 and related organ damage might persist throughout the disease course even in patients with a longer term of disease.
Preliminary findings of autopsy pathology revealed SARS-CoV-2 viral particles in multiple organs of several cases, suggesting a variety of viral
transmission routes such as the digestive tract, skin, and various body fluids (saliva, urine, semen, sweat and emulsion, etc.). These issues
merit further investigation.
https://watermark.silverchair.com/nw...PXFz_AkaSaFcuQ
Xiu-Wu Bian, the COVID-19 Pathology Team
Author Notes
National Science Review, nwaa123, https://doi.org/10.1093/nsr/nwaa123
Published:
06 June 2020
Abstract
Distribution of SARS-CoV-2 virus and pathological features of multiple organs in COVID-19 patients remains unclear, which interferes with the improvement of COVID-19 diagnosis and treatment. In this article, we summarize the pathological findings obtained from systematic autopsy (37 cases) and percutaneous multiple organ biopsy (“minimally invasive autopsy”, 54 cases). These findings should shed light on better understanding of the progression of COVID-19 infection and the means of more effective intervention.
----------------------
The postmortem discloses visible damages in the lung and immune organs in patients with COVID-19. Since some immune organs are SARS-CoV-2 positive with spleen atrophy, the immune organs may be another target organ by virus infection in addition to the lung, which emphasizes that clinical
diagnosis and treatment should consider the damages to immune system. We found that most of the deceased COVID-19 cases had mucous plug in
the alveoli and deep small airways, which might severely affect ventilation. The mechanisms of infection course and prevention measures were subject
of further investigation. In COVID-19 patients, pulmonary fibrosis occurred early and widely, suggesting that the requirement of early measures on
pulmonary fibrosis. In addition, the hyperplasia of pulmonary epithelial cells and the elevation of plasma carcinoembryonic antigen (CEA) in some patients
also require studies of the cause and follow-up.
In some deceased cases, nasopharyngeal swab test showed negative viral nucleic acid, but the acid could be detected in organs, suggesting that
current standard swab test for SARS-CoV-2 as an indicator for clinical cure and hospital discharge may not be adequate.
Detection of nuclear acids of SARS-CoV-2 in multiple organs of COVID-19 patients with severe conditions implies that the existence of SARS-
CoV-2 and related organ damage might persist throughout the disease course even in patients with a longer term of disease.
Preliminary findings of autopsy pathology revealed SARS-CoV-2 viral particles in multiple organs of several cases, suggesting a variety of viral
transmission routes such as the digestive tract, skin, and various body fluids (saliva, urine, semen, sweat and emulsion, etc.). These issues
merit further investigation.
https://watermark.silverchair.com/nw...PXFz_AkaSaFcuQ